Update on the adverse effects of clozapine: focus on myocarditis.
about
Etiology of cardiovascular disease in patients with schizophrenia: current perspectivesSignificant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subjectSystematic Review of Clozapine Cardiotoxicity.Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report.Clozapine prescribing in the UK: views and experience of consultant psychiatrists.An update of safety of clinically used atypical antipsychotics.Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Clozapine-induced myocarditis, a widely overlooked adverse reaction.Trends in the prescription of clozapine in a psychiatric hospital: a 5-year observational study.Persistence of racial disparities in prescription of first-generation antipsychotics in the USA.The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts.Clozapine-induced myocarditis may be associated with rapid titration: A case report verified with autopsy.Clozapine-induced myocarditis.Safety of long-term clozapine administration. Frequency of cardiomyopathy and hyponatraemia: two cross-sectional, naturalistic studies.Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and AgranulocytosisClozapine-induced myocarditis: Two case reports and review of clinical presentation and recognition
P2860
Q26778485-3CB55000-1E33-4F14-97D7-DCF54B59A94FQ28073082-4B04879C-0060-420D-BCFB-D9225AF9B83FQ30250192-BAAC9D0D-E21A-45F4-904A-D3B8DD9E95D9Q30490810-0D45429C-D30D-4609-8266-929D3DAB0EF3Q35906545-7F9627E7-B2D3-4319-B979-87A81B39CA00Q36062184-A0E662AE-4E2A-481D-9C8D-2517FDEE65A5Q38062444-E89F81DE-CD6C-4314-99DD-34B45AA0AEB8Q38417079-E3BD2DE9-F1CB-4598-9D40-765B6965E6D0Q38646571-AB8B79B8-7CAA-44B4-AD9F-59F53E5FCEEDQ40778551-1B69C95F-DE52-406F-BAB4-0C616A366622Q42221396-FDFBEF8D-D386-492F-8DDA-12D62AD4CC69Q46893940-171F905A-0C9E-4EF6-97A1-98FC2330A79DQ49221160-23501F88-09AC-4DB3-A857-9FE83DB579E1Q51335132-EA55FA6D-FC01-45AC-BDBE-49D1B66C16FDQ55232340-C2D2185F-C593-44C0-A5FB-58175976C8D8Q57491589-98E4DAEA-FD51-4253-BE49-290571CAD8D5Q58567904-A2CC7AC4-5787-455D-9AEA-D1F784F6869D
P2860
Update on the adverse effects of clozapine: focus on myocarditis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Update on the adverse effects of clozapine: focus on myocarditis.
@en
type
label
Update on the adverse effects of clozapine: focus on myocarditis.
@en
prefLabel
Update on the adverse effects of clozapine: focus on myocarditis.
@en
P2093
P1433
P1476
Update on the adverse effects of clozapine: focus on myocarditis.
@en
P2093
Alessandra Cicconetti
Alessandro Carano
Daniela Campanella
Domenico De Berardis
Francesca Ferri
Francesco Saverio Moschetta
Giovanni Martinotti
Luigi Olivieri
Marilde Cavuto
Massimo Di Giannantonio
P356
10.2174/157488612800492681
P577
2012-02-01T00:00:00Z